文献速递中毒与环境急症消化、代谢与肾脏急症

医生不愿干预成瘾问题:一项系统综述

Physician Reluctance to Intervene in Addiction: A Systematic Review.
PubMed 文献 · JAMA Netw Open · 2024-07-01
一句话结论系统综述显示医生不愿干预成瘾的最常见原因是缺乏机构支持(81.2%)、知识(71.9%)、技能(73.9%)和认知能力(73.5%)。

该研究系统检索了1960年1月1日至2021年10月5日的文献,最终纳入183项研究,涉及66732名医生报告的数据。大多数研究为调查数据,酒精、尼古丁和阿片类药物是研究最多的物质,筛查和治疗是研究最多的干预。医生不愿干预成瘾的最常见原因包括缺乏机构支持(173/213篇[81.2%])、知识(174/242篇[71.9%])、技能(170/230篇[73.9%])和认知能力(136/185篇[73.5%])。双变量分析显示这些原因与医生专业、干预类型和药物之间存在关联。作者认为,针对这些原因开展教育培训、政策制定和项目实施可能提高医生对循证实践的采纳。

要点

  • 缺乏机构支持是医生不愿干预成瘾的最常见原因,173/213篇文献(81.2%)报告了此原因。
  • 知识不足在174/242篇文献(71.9%)中被报告为医生不愿干预的原因。
  • 技能不足在170/230篇文献(73.9%)中被报告为医生不愿干预的原因。
  • 认知能力不足在136/185篇文献(73.5%)中被报告为医生不愿干预的原因。
  • 作者认为,针对机构支持、知识、技能和认知能力开展教育培训、政策制定和项目实施可能改善医生对成瘾循证实践的采纳。

适用人群与场景

  • 纳入包含医生的出版物,讨论物质使用干预并呈现医生不愿干预成瘾的原因数据。

处置流程与药物剂量

  • 作者认为,针对缺乏机构支持、知识、技能和认知能力这些原因开展教育和培训、政策制定和项目实施,可能改善医生对物质使用和成瘾护理循证实践的采纳。

研究设计与关键结果

  • 总共纳入183/9308篇检索到的研究,报告了来自66732名医生的数据。
  • 大多数研究报告调查数据;酒精、尼古丁和阿片类药物是研究最多的物质;筛查和治疗是研究最多的干预。
  • 最常见的不愿干预原因:缺乏机构支持(173/213篇[81.2%])、知识(174/242篇[71.9%])、技能(170/230篇[73.9%])、认知能力(136/185篇[73.5%])。
  • 还注意到报销担忧。
  • 双变量分析显示这些原因与医生专业、干预类型和药物之间存在关联。

证据类型、等级与局限

  • 证据类型:系统综述,遵循PRISMA指南,使用理论域框架提取原因。
  • 局限:未来关于医生报告的不愿采纳循证实践原因的研究可通过使用理论框架、提高对调查开发最佳实践的依从性和报告来改进;开发经过验证的调查工具可能进一步改善研究结果。

对床旁实践的改变

  • 作者认为,针对缺乏机构支持、知识、技能和认知能力,通过教育和培训、政策制定和项目实施,可能提高医生对物质使用和成瘾护理循证实践的采纳。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The overdose epidemic continues in the US, with 107 941 overdose deaths in 2022 and countless lives affected by the addiction crisis. Although widespread efforts to train and support physicians to implement medications and other evidence-based substance use disorder interventions have been ongoing, adoption of these evidence-based practices (EBPs) by physicians remains low.

OBJECTIVE: To describe physician-reported reasons for reluctance to address substance use and addiction in their clinical practices using screening, treatment, harm reduction, or recovery support interventions.

DATA SOURCES: A literature search of PubMed, Embase, Scopus, medRxiv, and SSRN Medical Research Network was conducted and returned articles published from January 1, 1960, through October 5, 2021.

STUDY SELECTION: Publications that included physicians, discussed substance use interventions, and presented data on reasons for reluctance to intervene in addiction were included.

DATA EXTRACTION AND SYNTHESIS: Two reviewers (L.N., M.C., L.F., J.P., C.S., and S.W.) independently reviewed each publication; a third reviewer resolved discordant votes (M.C. and W.C.). This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines and the theoretical domains framework was used to systematically extract reluctance reasons.

MAIN OUTCOMES AND MEASURES: The primary outcome was reasons for physician reluctance to address substance use disorder. The association of reasons for reluctance with practice setting and drug type was also measured. Reasons and other variables were determined according to predefined criteria.

RESULTS: A total of 183 of 9308 returned studies reporting data collected from 66 732 physicians were included. Most studies reported survey data. Alcohol, nicotine, and opioids were the most often studied substances; screening and treatment were the most often studied interventions. The most common reluctance reasons were lack of institutional support (173 of 213 articles [81.2%]), knowledge (174 of 242 articles [71.9%]), skill (170 of 230 articles [73.9%]), and cognitive capacity (136 of 185 articles [73.5%]). Reimbursement concerns were also noted. Bivariate analysis revealed associations between these reasons and physician specialty, intervention type, and drug.

CONCLUSIONS AND RELEVANCE: In this systematic review of reasons for physician reluctance to intervene in addiction, the most common reasons were lack of institutional support, knowledge, skill, and cognitive capacity. Targeting these reasons with education and training, policy development, and program implementation may improve adoption by physicians of EBPs for substance use and addiction care. Future studies of physician-reported reasons for reluctance to adopt EBPs may be improved through use of a theoretical framework and improved adherence to and reporting of survey development best practices; development of a validated survey instrument may further improve study results.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Campopiano von Klimo M, Nolan L, Corbin M, et al. Physician Reluctance to Intervene in Addiction: A Systematic Review. JAMA Netw Open. 2024. PMID: 39018077. doi:10.1001/jamanetworkopen.2024.20837

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。